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Objectives. This study examined the influence of left ventricular 
hypertrophy on the accuracy of exercise lectrocardiography and 
echocardiography for detection of coronary artery disease. 
Background. Electrocardiographic repolarization abnormali- 
ties caused by left ventricular hypertrophy compromise the diag- 
nostic accuracy of exercise lectrocardiography hut not of exercise 
echocardiography. The relative merits of these investigations are 
less well defined in patients with hypertrophy but without electro- 
cardiographic (ECG) changes. 
Methods. We prospectively evaluated 147 consecutive patients 
without prior myocardial infarction undergoing both exercise 
echocardiography and coronary arteriography. Coronary stenoses 
>50% diameter were present in 62 patients (42%). Positive test 
results were defined by a new or worsening wall motion abnor- 
mality or >0.1 mV of ST depression. Echocardiographic left 
ventricular hypertrophy (mass >131 g/m 2 in men, >100 g/m 2 
in women) was identified in 68 patients. A subgroup with clin- 
ically suspected hypertrophy was defined according to the pres- 
ence of ECG evidence of hypertrophy, hypertension or aortic 
stenosis. 
Results. The overall sensitivity of exercise chocardiography 
exceeded that of exercise lectrocardiography (71% vs. 54%, p = 
0.06). Echocardiographic hypertrophy had no significant effect 
on the sensitivity of either test. The specificity of exercise echo- 
cardiography exceeded that of exercise lectrocardiography (91 vs. 
74%, p = 0.01). In patients with hypertrophy, the specificity of 
exercise echocardiography exceeded that of exercise lectrocardio- 
graphy (95% vs. 69%, p < 0.01), whereas among patients without 
hypertrophy, the specificities (respectively, 87% and 78%) were 
more comparable. The accuracy of exercise echocardiography 
exceeded that of the exercise ECG in the overall group (82% vs. 
65%, p --- 0.002) and in patients with hypertrophy (85% vs. 60%, 
p = 0.004), but this difference was less prominent in patients 
without hypertrophy (80% vs. 69%, p -- NS). In patients with 
clinically suspected hypertrophy, exercise echocardiography dem- 
onstrated a higher sensitivity, specificity and accuracy than 
exercise electrocardiography. The cost incurred in the identifica- 
tion of coronary disease was least with a strategy involving use of 
the exercise echocardiogram instead of routine exercise testing in 
patients with known or clinically suspected left ventricular hyper- 
trophy. 
Conclusions. Exercise echocardiography is more accurate than 
exercise electrocardiography for the detection of coronary artery 
disease in patients with known or clinically suspected left ventric- 
ular hypertrophy. 
(J Am Coil Cardio11995;26".1180- 6) 
Left ventricular hypertrophy and coronary artery disease fre- 
quently occur in combination, and the noninvasive identifica- 
tion of coronary artery disease in this setting may be difficult. 
The results of exercise electrocardiography are often un- 
reliable because of repolarization abnormalities (1,2) but 
may be compromised even in the absence of electrocardio- 
graphic (ECG) evidence of hypertrophy (3). Myocardial hy- 
pertrophy is not necessarily paralleled by a commensurate 
increase in the coronary vasculature (4,5). Nonuniform im- 
pairment of coronary flow reserve by left ventricular hyper- 
trophy (rather than coronary artery disease) may lead to 
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false positive perfusion defects, reducing the specificity of 
myocardial perfusion scintigraphy to the level of 65% (6-8). 
The sensitivity of perfusion imaging may also be compro- 
mised (9). 
The specificity of dobutamine stress echocardiography in 
patients with left ventricular hypertrophy appears to be supe- 
rior to that of myocardial perfusion imaging (10). However, 
global left ventricular functional reserve is known to be 
compromised in the setting of hypertension a d left ventricular 
hypertrophy (11), and the impact of left ventricular hypertro- 
phy on the accuracy of stress echocardiography as not been 
studied in a large group. The present study was designed to 
evaluate the effect of left ventricular hypertrophy on the 
diagnosis of coronary artery disease using exercise chocardi- 
ography and to compare the results and cost implications of 
using exercise chocardiography and the exercise ECG for the 
diagnosis of coronary artery disease in patients with known and 
suspected left ventricular hypertrophy. 
©1995 by the American ('ollcgc oi ('ardi~t~g} 0735-1097/95/$9.50 
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Methods  
Patient selection. Over a period of 21 months, 178 consec- 
utive patients who underwent coronary arteriography also had 
exercise stress echocardiography for the diagnosis or evalua- 
tion of clinically suspected coronary artery disease. Patients 
(n = 31) with historical, ECG or echocardiographic evidence 
of myocardial infarction were excluded. Thus, the study group 
included 147 patients (mean [_+SD] age 58 _+ 12 years, range 
28 to 80; 60 women, 87 men). Left ventricular hypertrophy was 
suspected on clinical grounds in 70 patients (48%), including 
18 with ECG evidence of hypertrophy and 52 with hyperten- 
sion or significant aortic stenosis. Sixty-three patients (43%) 
were taking beta-adrenergic or calcium antagonists. 
Exercise electrocardiography. Twelve-lead ECGs were re- 
corded at rest and during stress in all patients and were 
interpreted by an independent observer. The rest ECG re- 
corded with standard lead positioning was evaluated for evi- 
dence of left ventricular hypertrophy (12). The rest recording 
was also used to identify ECG patterns producing a nondiag- 
nostic exercise ECG (including left ventricular hypertrophy 
with strain, left bundle branch block and digitalis effect); 
stress-induced ST segment changes in the presence of these 
were identified as nondiagnostic. 
Symptom-limited treadmill exercise tests were performed ina 
routine manner (13), with the protocol selected in accordance 
with the cardiovascular nd general physical capacity of each 
subject. Patients attained an average stimated work capacity 
of 7.4 _+ 2.7 metabolic equivalents (METs) and a peak 
rate-pressure product of 26.3 _ 6.5 x 103 at a peak heart rate 
of 146 _ 26 beats/min (90 _+ 13% of age-predicted maximum). 
Exercise ECGs were interpreted independent of the results of 
exercise chocardiography or coronary angiography; a positive 
test result was defined by the presence of horizontal or 
downsloping ST segment depression >0.1 mV at an interval of 
0.08 s after the J point in any lead (13). 
Echocardiographic examination. M-mode and two- 
dimensional echocardiography were performed with standard 
ultrasound imaging equipment, and the images were digitized 
on-line (PreVue or ImageVue, Nova Microsonics). Rest left 
ventricular dimensions were measured, in accordance with 
American Society of Echocardiography recommendations 
(14). Two-dimensional images were obtained in the left lat- 
eral decubitus position before and immediately (usually 
<1 min) after treadmill exercise in parasternal long- and 
short-axis and apical four- and two-chamber views. These data 
were recorded on 0.5-in. VHS videotape and also digitally for 
off-line review. 
Interpretation of the exercise cchocardiogram was per- 
formed on a segmental basis, using a standard 16-segment 
model of the left ventricle encompassing posterior, inferior, 
lateral, anterior, anteroseptal and septal segments at the basal 
and midventricular levels and inferior, lateral, anterior and 
septal segments at the apex. This interpretation was made in 
each consecutive patient, irrespective of image quality, by the 
consensus of at least wo observers uninformed ofthe results of 
exercise lectrocardiography andcoronary arteriography. Isch- 
emia was identified by failure to augment wall motion relative 
to other segments or deterioration of regional function. Aki- 
nesia or dyskinesia at rest was defined as infarction, and 
subjects with these findings were excluded from the study 
group. The intraobserver and interobserver concordances were 
96% and 81%, respectively. 
Calculation of left veutricular mass. Left ventricular mass 
(LVM) was calculated from rest images showing the left 
ventricular diastolic dimension (LVID [cm]), posterior wall 
thickness (PWT [cm]) and septal wall thickness (SWT [cm]) 
using the regression-corrected "cube formula" (15): 
Echocardiographic LVM = 1.04[(LVID + PWT + SWT) 3 - (LVID)3]. 
The echocardiographic left ventricular mass was then cor- 
rected for necropsy left ventricular mass by applying the 
following equation (16): 
Corrected LVM (g) = 0.8 (Echocardiographic LVM) + 0.6 g. 
Left ventricular mass index was then calculated by dividing the 
echocardiographic left ventricular mass by body surface area. 
Gender-specific normal limits from the Framingham Heart 
Study (17) were used to define left ventricular hypertrophy on 
the basis of a left ventricular mass index >100 g/m 2 for women 
and >131 g/m 2 for men. 
Coronary arteriography. Arteriograms were acquired rou- 
tinely for all 178 patients and recorded on cine film. The 
presence of significant coronary artery disease was defined by 
an experienced angiographer on the basis of measurement of 
>50% diameter stenosis in a major epicardial vessel. Thirty of 
the 62 patients with coronary disease had multivessel disease. 
Data analysis. A true positive finding was defined as any 
echocardiographic wall motion abnormality in an area of 
myocardium that was supplied by a major epicardial coronary 
artery with a stenosis >50%. The absence of a wall motion 
abnormality in a myocardial segment subtended by a signifi- 
cant stenosis was defined as a false negative finding. In the 
absence of significant coronary stenosis, abnormal wall motion 
was classified as a false positive finding, and the combination 
of no wall motion abnormality in a segment supplied by a 
coronary vessel without significant stenosis was defined as a 
true negative finding. Sensitivity, specificity, accuracy and 
predictive values were calculated in the usual manner. 
Categoric results were compared between the groups using 
McNemar's test for paired data and the chi-square test for 
unpaired data. Continuous variables were compared using 
two-way analysis of variance. 
Cost analysis. The study group was divided into subgroups 
with and without left ventricular hypertrophy on echocardio- 
graphic and clinical grounds, and the cost of investigation was 
calculated for two diagnostic strategies: 1) use of the exercise 
ECG in all patients, with use of exercise chocardiography 
in those with uninterpretable rest ECGs; and 2) use of the 
exercise echocardiogram in all patients. Calculations were 
based on the reimbursement levels currently applied by Medi- 
care in our area ($1,424 for a coronary angiogram, $246 for an 
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Table 1. Comparison ofClinical, Exercise and Angiographic 
Variables in Patients With and Without Echocardiographic Evidence 
of Left Ventricular Hypertrophy 
Echo No Echo 
LVH LVH p 
(n = 68) (n : 79) Value 
Age (yr) 58 -+ 10 56 ± 12 0.32 
Body surface area (m 2) 1.8 -+ 0.2 2.0 _+ 0.2 0.01 
Antianginal therapy 17 (25%) 14 (18%) 0.28 
Exercise capacity (METs) 7.0 : 3 7.0 ± 3 0.51 
Peak HR (% age predicted) 89 -- 13 89 ± 12 0.62 
Peak RPP (×103) 25.0 -+ 7.1 25.0 ± 5.6 0.64 
Patients with coronary disease 28 (41%) 34 (43%) 0.82 
Patients with multivessel disease 19 (28%) 9 (11%) 0.02 
ECG features of LVH 15 (22%) 3 (4%) 0.0180 
ECG LVH, hypertension, LV 43 (63%) 27 (34%) 0.0004 
outflow obstruction 
Data presented are mean value +_ or number (%) of patients. Echo = 
echocardiographic; ECG = electrocardiographic; HR = heart rate; LV - left 
ventricular; LVH = left ventricular hypertrophy; METs = metabolic equivalents; 
RPP = rate-pressure product. 
exercise chocardiogram and $63 for an exercise ECG). The 
total cost of a diagnostic strategy should reflect not only the 
charges for the initial test but also those associated with 
coronary angiography because patients with positive test re- 
sults usually proceed to this study. Hence, cost was derived 
from the expense of the initial test (exercise electrocardio- 
graphy or exercise chocardiography) together with that of the 
coronary angiogram in patients with positive test results. 
Results were expressed as the cost for investigating the group 
as a whole (on a cost per patient basis) and that expended for 
the diagnosis of each patient with coronary disease. 
Resul ts  
Clinical characteristics. Of the 147 patients, 68 had echo- 
cardiographic evidence of left ventricular hypertrophy, with an 
average left ventricular mass of 155 _ 38 g/m 2, and 79 had no 
hypertrophy (average left ventricular mass 97 _+ 19 g/m2). The 
clinical, exercise and angiographic features of patients with and 
without left ventricular hypertrophy are compared in Table 1. 
Electrocardiographic evidence of left ventricular hypertrophy 
(8) was present in only 18 patients overall, including 15 (22%) 
in the group of 68 with and 3 (4%) of the group without 
echocardiographic evidence of left ventricular hypertrophy 
(p < 0.02). Addition of 52 patients who had clinical factors 
associated with increased left ventricular mass (hypertension, 
left ventricular outflow obstruction) to the group with ECG 
changes increased the number of patients with "clinically 
suspected" left ventricular hypertrophy to 70. Forty-three of 
these 70 patients were among the 68 patients with left ventric- 
ular hypertrophy by echocardiography (63%), whereas only 27 
had normal left ventricular mass by echocardiography (34%, 
p < 0.001). However, both groups were of similar age and 
showed a similar prevalence of coronary artery disease. 
Exercise electrocardiography. Patients with eehocardio- 
graphic left ventricular hypertrophy demonstrated a similar 
exercise capacity and hemodynamic response to exercise as 
those with normal left ventricular mass (Table 1). The ECG 
was uninterpretable for ischemia in 24 patients because of rest 
repolarization abnormalities secondary to left bundle branch 
block (n = 4), left ventricular hypertrophy with a "strain" 
pattern (n = 8) or digitalis therapy (n = 12). Table 2 compares 
the results of exercise lectrocardiography in the remaining 
123 patients according to those with and without echocardio- 
graphic evidence of left ventricular hypertrophy. The sensitiv- 
ity of the exercise ECG was similar in subgroups with and 
without echocardiographic evidence of left ventricular hyper- 
trophy (respectively, 50% and 58%, p = NS). The specificity of 
the exercise ECG was not significantly less in those with than 
without left ventricular hypertrophy (69% vs. 78%, p = NS). 
Accuracy was also similar in both groups (60% vs. 69%, p = 
NS). 
Table 2. Comparison ofSensitivity, Specificity and Accuracy of Exercise Electrocardiography (in 
patients with interpretable STsegments) and Echocardiography in Patients With Echocardiographic 
Evidence of Left Ventricular Hypertrophy and Normal Left Ventricles 
No Echo p Value 
All Pts Echo LVH LVH (LVH vs. none) 
Sensitivity 
ExEcho 44/62 (71%) 20/28 (71%) 24/34 (71%) 1.00 
ExECG 31/57 (54%) 12/24 (50%) 19/33 (58%) 0.77 
p value (ExECG vs. ExEcho) 0.06 0.19 0.27 
Specificity 
ExEcho 77/85 (91%) 38/40 (95%) 39/45 (87%) 0.35 
ExECG 49/66 (74%) 20/29 (69%) 29/37 (78%) 0.56 
p value (ExECG vs. ExEcho) 0.01 0.01 0.49 
Accuracy 
ExEcho 121/147 (82%) 58/68 (85%) 63/79 (80%) 0.38 
ExECG 80/123 (65%) 32/53 (60%) 48/70 (69%) 0.35 
p value (ExECG vs. ExEcho) 0.002 0.004 0.12 
Data presented are number (%) of patients (Pts), ExECG = exercise lectrocardiogram; ExEcho = exercise 
cchocardiogram; other abbreviations a  in Table 1. 
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Table 3. Clinical Characteristics of 18 Patients With False Negative Results on Exercise Echocardiograms 
Antianginal Agent LV 
% Age- Peak Mass 
Pt No./ Age Calcium Beta- Peak HR Predicted SBP Exercise ECG No. of Vessels Diseased Index 
Gender (yr) Nitrate Blocker Blocker METs (beats/min) Max HR (mm Hg) Results (vessel % stenosis) (g/m 2) 
1/M 52 Y Y Y 11 121 70 160 Normal 1 (RCA 95%) 98 
2/M 57 N Y Y 10 152 93 191 Normal 2 (LC-~ 100%, RCA 90%) 164 
3/M 62 N Y N 3 128 81 156 Nondiagnostic 3 (LAD 70%, ~ 70%, RCA 60%) 140 
(digoxin) 
4/M 50 N Y N l0 160 94 204 ST depression 2 mm 1 (RCA 55%) 160 
5/M 51 N N N 10 153 90 172 ST elevation 3 mm 2 (LAD 80%, RCA 95%) 65 
6/M 64 N Y N 10 133 85 211 Normal 1 (LAD 55%) 72 
7/F 48 N N N 5 112 65 116 Normal 2 (LAD 65%, LCx 55%) 79 
8/M 52 N N N 11 161 96 192 ST depression 1 mm 2 (LAD 50%, LCx 70%) 128 
9/M 49 N Y N 13 161 94 255 Normal 1 (LAD 70%) 161 
10/M 36 N N Y 13 165 88 196 Normal l (LAD 85%) 109 
l l/M 43 N Y N I I 150 85 213 Normal 1 (RCA 100%) 151 
12/F 50 N N N 5 129 76 178 Normal 1 (LAD 60%) 83 
13/M 47 N Y N 9 173 100 197 ST depression I mm 1 (RCA 50%) 138 
14/M 62 N N Y 6 171 108 193 Normal 1 (LAD 60%) 89 
15/M 55 N Y N 7 154 83 200 Normal 2 (RCA 100%, LCx 60%) 159 
16/M 76 N N N 8 125 87 160 Normal 1 (LAD 70%) 52 
17/F 57 N N N 6 163 100 190 Normal 1 (LAD 90%) 76 
18/M 60 N Y N 9 154 93 212 Normal 1 (LAD 70%) 161 
F = female; LAD = left anterior descending coronary artery; LCx = left circumflex coronary artery; M = male; N = no; Pt = patient; RCA = right coronary artery; 
SBP = systolic blood pressure; Y = yes; other abbreviations as in Table 1. 
Exercise echocardiography. All exercise echocardiograms 
were interpreted. Overall, the sensitivity of exercise chocar- 
diography in 62 patients with coronary artery disease was 71%. 
In 32 patients with single-vessel disease it was 63% compared 
with 80% in 30 patients with multivessel disease. Specificity 
was 91% in 85 patients without coronary artery disease, and 
overall accuracy was 82%. Table 2 illustrates the results of the 
exercise echocardiogram in all 147 patients according to 
presence or absence of echocardiographic evidence of left 
ventricular hypertrophy. The sensitivity of the exercise echo- 
cardiogram was 71% in patients both with and without left 
ventricular hypertrophy (p = NS). The specificity of the 
exercise chocardiogram was 95% in the 40 patients with and 
87% in the 45 without hypertrophy (p = NS). Overall accuracy 
in patients with left ventricular hypertrophy (85%) was com- 
parable to that in patients with normal left ventricular mass 
(80%, p = NS). Left ventricular mass index in patients with 
accurate xercise chocardiographic results was 127 ± 41 g/m 2 
compared with 111 _+ 39 g/m 2 in patients with incorrect results 
(p : NS). 
Data for the 18 patients with false negative results on the 
exercise chocardiograms are shown in Table 3. Five patients 
(two with echocardiographic ypertrophy, three without) exer- 
cised submaximally; exclusion of these as "nondiagnostic" 
results would adjust the overall sensitivity to 77%. False 
negative results in the setting of left ventricular hypertrophy 
were significantly more associated with calcium or beta- 
adrenoceptor antagonist therapy than in those without hyper- 
trophy (p < 0.01), but the difference in treatment was less 
prominent in patients with true positive results. Of the patients 
with coronary artery disease and negative xercise choeardio- 
graphic results, 67% had single-vessel disease; in contrast only 
45% of patients with coronary artery disease and positive 
exercise chocardiographic results had single-vessel disease. 
Comparison of exercise ECG and exercise echocardiogra. 
phy. The paired results of exercise electrocardiography and 
echocardiography in patients with an interpretable xercise 
ECG, with and without echocardiographic evidence of left 
ventricular hypertrophy, are illustrated in Figure 1. Analysis of 
these paired data showed the exercise echocardiogram to be 
more sensitive than the ECG, regardless of the presence of left 
ventricular hypertrophy. However, even after the exclusion of 
Figure 1. Sensitivity and specificity of exercise lectrocardiography 
(ExECG [stippled bars[) and echocardiography (ExEcho [hatched 
bars]) in patients (n) with an interpretable electrocardiogram, with 
(LVH) and without (NLV) left ventricular hypertrophy. 
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Table 4. Comparison of Sensitivity, Specificity and Accuracy of Exercise Electrocardiography (in 
patients with interpretable studies) and Echocardiography in Patients With and Without Clinically 
Suspected Left Ventricular Hypertrophy 
Clinical No Clinical p 
All Pts LVH LVH Value 
Sensitivity. 
ExEcho 44,,'62 (71%) 24/32 (75%) 20/30 (67%) 0.47 
ExECG 31/57 (54%) 13/27 (48%) 18/30 (60%) 0.37 
p value (ExECG vs. ExEcho) 0.06 0.03 0.59 
SpecificiW 
ExEcho 77/85 (91%) 34/38 (80%) 43/47 (91%) 1.00 
ExECG 49/66 (74~,I) 17/25 (68%) 32/41 (78%) 0.54 
p value (ExECG vs. ExEcho) 0,007 0.04 0.07 
Accuracy 
ExEcho 121/147 (82%) 58/70 (83%) 63/77 (82%) 0.87 
ExECG 80/123 (65%) 30/52 (58%) 50/71 (70%) 0.14 
p value (ExECG vs. ExEcho) 0,001 0.002 0.10 
Data presented are number (%) of patients (Pts). Clinical LVH - clinically suspected left ventricular hypertrophy 
(by exercise lectrocardiogram [ExECG], hypertension or aortic valve disease); ExEcho = exercise chocardiogram. 
patients whose rest ECG made their exercise ST segment 
response uninterpretable, the specificity and accuracy of the 
exercise ECG were inferior to those of the exercise echocar- 
diogram in patients with echocardiographic left ventricular 
hypertrophy. However, the differences between the two tests in 
patients without echocardiographic ypertrophy were not sig- 
nificant. 
Although clinical predictors of increased left ventricular 
mass (ECG left ventricular hypertrophy, hypertension raortic 
stenosis) were present in 63% of patients with echocardio- 
graphic left ventricular hypertrophy, they were also present in 
34% of those without hypertrophy. The results of exercise 
echocardiography and exercise lectrocardiography, in relation 
to the presence or absence of clinical suspicion of hypertrophy, 
are shown in Table 4. In patients who were suspected clinically 
to have left ventricular hypertrophy, exercise echocardiogra- 
phy demonstrated significantly greater sensitivity, specificity 
and accuracy than the exercise ECG. 
Cost implications of incorporation of exercise chocardiog- 
raphy in diagnosis of coronary artery disease. Table 5 de- 
scribes the numbers of false negative results, numbers of 
studies and cost (based on the Medicare reimbursements) 
associated with exercise chocardiographic and ECG strategies 
for the diagnosis of coronary disease in the overall group and 
in those with echocardiographic ypertrophy or clinically sus- 
pected hypertrophy. In the overall group, the initial use of 
exercise chocardiography was associated with 33% fewer false 
negative results than the use of the exercise ECG (with 
echocardiography limited to patients with nondiagnostic exer- 
cise ECGs) at 24% greater cost. In patients with echocardio- 
graphic left ventricular hypertrophy, the performance of exer- 
cise echocardiography ledto 38% fewer false negative findings 
at 25% greater cost. Use of exercise echocardiography in 
patients with clinically suspected left ventricular hypertrophy 
led to 47% fewer false negative results at 28% greater cost. 
However, exercise echocardiography was the less expensive 
approach when these data were combined by assessing the cost 
for identification of each patient with coronary disease. 
Discuss ion 
The results of the present study of the influence of left 
ventricular hypertrophy on diagnosis of coronary artery disease 
suggest that exercise echocardiography is superior to the 
Table 5. Proportion of False Negative Study Results, Number of Studies and Cost of Exercise Echocardiography and Electrocardiography 
Cost 
Diagnostic False Negative Angio Per Pt 
Approach [no. (%) of pts] ExECG ExEcho [no. (%) of pts] Per Pt With CAD 
All pts (n - 147 [62 with CAD]) ExEcho 18 (29%) 0 147 52 (35%) $750 $2,506 
ExECG* 27 (44%) 123 24 53 (36%) $606 $2,545 
Pts with known LVH (n - 68 [28 with CAD]) ExEcho 8 (29%) 0 68 22 (32%) $707 $2,404 
ExECG* 13 (46%) 53 15 22 (32%) $564 $2,557 
Pts with suspected LVH (n - 70 132 with CAD]) ExEcho 8 (25%) 0 70 28 (40%) $816 $2,380 
ExECG* 15 (47~;-) 52 18 26 (37%) $639 $2,631 
*Exercise echocardiogram (ExEcho) used for patients (Pts) with uninterpretable exercise lectrocardiogram (ExECG). Angio - angiography; CAD = coronary 
artery disease; LVH = left ventricular hypertrophy. 
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exercise ECG in patients with both echocardiographic and 
clinically suspected left ventricular hypertrophy. In particular, 
the specificity of exercise chocardiography is not influenced 
by the presence of left ventricular hypertrophy. This finding 
contrasts with the lower specificity of exercise lectrocardio- 
graphy in patients with both echocardiographic and clinically 
suspected hypertrophy, even in the presence of "interpretable" 
ECG results. However, the sensitivity of this technique may be 
compromised bythe administration f antihypertensive agents. 
In our theoretic estimation of expenditure, the additional cost 
of echocardiography is balanced by reduction of unnecessary 
angiography in patients with false positive results. In these 
respects, exercise chocardiography appears to be less influ- 
enced by coexistent hypertrophy than are other conventional 
noninvasive tests for coronary artery disease. 
Factors influencing accuracy of tests used for detection of 
coronary disease. The sensitivity of exercise electrocardio- 
graphy and echocardiography for detection of coronary artery 
disease are dependent on the patient under study. The sensi- 
tivity of the exercise ECG is well known to show substantial 
variability (18). The low sensitivity in the present study reflects 
the prevalence of patients receiving medical therapy and with 
single-vessel disease. Previous reports of post-treadmill exer- 
cise echocardiography s ow that sensitivity varies from 70% to 
80% in patients without infarction (19,20) or multivessel 
disease (21) to 80% to 90% with the inclusion of patients with 
multivessel disease and myocardial infarction (22,23). An 
inverse correlation also exists between reported sensitivity and 
specificity (24), reflecting the threshold of the observer for 
identifying segments as normal or abnormal (a low threshold 
leads to fewer false negative but more false positive results). 
The accuracy of exercise chocardiography in the present study 
is comparable tothat recorded in similar groups that excluded 
patients with previous infarction (19,20). 
A particular problem in patients with left ventricular hyper- 
trophy is the use of calcium antagonists and beta-blocking 
drugs for the treatment of hypertension, which protect he 
heart from the development of ischemia nd therefore cause 
false negative xercise echocardiographic results (25,26). In 
our study group, all these factors are probably responsible for 
lower levels of sensitivity (especially in patients with single- 
vessel disease) than might otherwise have been attained in 
another cohort hat included more patients with infarction and 
multivessel disease and had a lower prevalence of medical 
therapy. 
Detection of coronary artery disease in patients with left 
ventricular hypertrophy. Patients with electrocardiographic 
evidence of left ventricular hypertrophy, associated with repo- 
larization abnormalities, are prone to develop additional ST 
segment changes unrelated to the presence of coronary artery, 
disease. Similarly, coronary flow reserve is impaired in the 
setting of hypertrophy (27,28), and this may influence the 
results of perfusion scintigraphy (8). To our knowledge, no 
previous tudies have examined the role of exercise chocar- 
diography in the diagnosis of coronary artery disease in 
patients with left ventricular hypertrophy. Although global 
disturbances in the left ventricular wall motion response to 
stress have been reported in patients with hypertrophy (11), 
the interpretation f exercise chocardiograms is dependent 
on the evaluation of regional rather than global dysfunction. 
The present study demonstrates that the results of exercise 
echocardiography in patients with left ventricular hypertrophy 
are equivalent to those without hypertrophy and are compa- 
rable to those in unselected patients in published reports 
(19-24). Moreover, the results of our study show that the 
benefit of using exercise chocardiography as the primary test 
is apparent in patients with clinically suspected hypertrophy. 
Cost considerations. Although the exercise echocardio- 
gram may offer greater accuracy than the ECG in the setting of 
left ventricular hypertrophy, the cost implications of using 
exercise chocardiography as aprimary test provide an impor- 
tant consideration i  the current medical economy. Our anal- 
ysis shows that in the overall group and in patients with known 
or suspected left ventricular hypertrophy, the use of exercise 
echocardiography offers a 25% to 47% reduction in false 
negative results at a small increase in cost per patient studied 
but a lower cost per patient detected with coronary artery 
disease. However, this analysis has some important limitations: 
1) It pertains to the case mix of the present study in which 42% 
of patients had coronary disease; 2) we assumed that most 
patients with positive noninvasive test results proceed to 
angiography, although in clinical practice this decision is 
obviously colored by other data. As the latter process is difficult 
to model, analysis of the cost of investigation with either 
approach was simplified to reflect the numbers and cost of 
angiograms inpatients with positive stress test results, together 
with the charges associated with each form of stress test. 3) The 
cost of a false negative test result was not incorporated into the 
present evaluation because this is difficult o quantify. Hence, 
the cost analysis should be balanced by the proportion of 
patients with false negative results. 
Clinical implications. The results of the present study 
suggest that in contrast to other noninvasive t sts, the results of 
exercise stress echocardiography forthe detection of coronary 
artery disease are not compromised by left ventricular hyper- 
trophy. The specificity of ST segment interpretation relative to 
the exercise chocardiogram is compromised by the presence 
of left ventricular hypertrophy, even in patients who do not 
have rest ST segment changes. Exercise chocardiography may 
be the test of choice for the detection of coronary artery 
disease in patients with echocardiographic or clinically sus- 
pected left ventricular hypertrophy. 
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